drugset / Trial / NCT02411578

Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

NCT02411578 ↗

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine if a small dose of glucagon (mini-dose glucagon) is effective for the treatment of non-severe hypoglycemia in adults with type 1 diabetes (T1D).

Timeline

Start
2015-09
Primary completion
2016-04
Completion
2016-05

Outcome

Missed primary endpoint

paper 58 (94%) of 62 events during the MDG period and 53 (95%) of 56 events during the glucose tablets (TABS) period (adjusted P = 0.99). PMID 28591776 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucagon Peptide 150 ug —
Subject Glucagon Peptide 300 ug —